Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Abstract Alzheimer's disease (AD) is one of the chief neurological difficulties in the aged population, identified through dementia, memory disturbance, and reduced cognitive abilities. β‐amyloid (Aβ) plaques aggregations, generation of reactive oxygen species, and mitochondrial dysfunction are...
Saved in:
Main Authors: | Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei, Seyran Kakebaraei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | IET Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1049/nbt2.12127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01) -
CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01) -
Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01) -
Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01) -
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01)